Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Stefano Piaserico and Simone Cazzaniga.
Stefano Piaserico
Connection Strength
0.930
Simone Cazzaniga
  1. Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence. J Invest Dermatol. 2022 02; 142(2):355-363.e7.
    View in: PubMed
    Score: 0.240
  2. Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? J Eur Acad Dermatol Venereol. 2021 Jun; 35(6):e355-e357.
    View in: PubMed
    Score: 0.233
  3. Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy. Am J Clin Dermatol. 2020 10; 21(5):749-751.
    View in: PubMed
    Score: 0.226
  4. Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs. Dermatol Ther (Heidelb). 2021 Aug; 11(4):1333-1343.
    View in: PubMed
    Score: 0.060
  5. Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review. Dermatol Ther (Heidelb). 2021 Jun; 11(3):695-705.
    View in: PubMed
    Score: 0.059
  6. Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience. J Allergy Clin Immunol. 2021 Feb; 147(2):558-560.e1.
    View in: PubMed
    Score: 0.057
  7. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. Br J Dermatol. 2020 08; 183(2):373-374.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.